A Study of BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor Symptoms
Status:
Completed
Trial end date:
2019-11-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of BAY3427080 (NT-814), taken
once a day, in the treatment of troublesome post-menopausal symptoms.